Shaker Investments LLC OH Has $1.29 Million Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Shaker Investments LLC OH grew its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT) by 0.8% in the fourth quarter, HoldingsChannel.com reports. The fund owned 13,948 shares of the medical instruments supplier’s stock after buying an additional 112 shares during the period. Shaker Investments LLC OH’s holdings in LeMaitre Vascular were worth $1,285,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other institutional investors also recently modified their holdings of LMAT. The Manufacturers Life Insurance Company increased its position in LeMaitre Vascular by 5.9% during the second quarter. The Manufacturers Life Insurance Company now owns 10,469 shares of the medical instruments supplier’s stock worth $861,000 after buying an additional 583 shares during the last quarter. Truist Financial Corp boosted its stake in shares of LeMaitre Vascular by 92.1% during the 2nd quarter. Truist Financial Corp now owns 7,054 shares of the medical instruments supplier’s stock worth $580,000 after acquiring an additional 3,381 shares during the period. GAMMA Investing LLC increased its holdings in shares of LeMaitre Vascular by 34.3% during the 3rd quarter. GAMMA Investing LLC now owns 736 shares of the medical instruments supplier’s stock worth $68,000 after acquiring an additional 188 shares during the last quarter. Creative Planning raised its stake in LeMaitre Vascular by 20.7% in the 3rd quarter. Creative Planning now owns 3,594 shares of the medical instruments supplier’s stock valued at $334,000 after acquiring an additional 617 shares during the period. Finally, NBC Securities Inc. lifted its holdings in LeMaitre Vascular by 73.2% during the 3rd quarter. NBC Securities Inc. now owns 433 shares of the medical instruments supplier’s stock valued at $40,000 after purchasing an additional 183 shares during the last quarter. 84.64% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at LeMaitre Vascular

In related news, Director Bridget A. Ross sold 3,750 shares of the firm’s stock in a transaction on Friday, November 15th. The stock was sold at an average price of $101.47, for a total value of $380,512.50. Following the transaction, the director now owns 2,278 shares in the company, valued at approximately $231,148.66. This trade represents a 62.21 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Insiders own 10.79% of the company’s stock.

LeMaitre Vascular Trading Up 0.5 %

NASDAQ LMAT opened at $98.44 on Tuesday. The company has a market cap of $2.21 billion, a price-to-earnings ratio of 53.79, a PEG ratio of 2.19 and a beta of 0.96. LeMaitre Vascular, Inc. has a 1-year low of $58.66 and a 1-year high of $109.58. The company has a 50 day moving average of $96.58 and a 200-day moving average of $93.28.

Wall Street Analyst Weigh In

Several equities analysts have commented on the stock. StockNews.com downgraded shares of LeMaitre Vascular from a “buy” rating to a “hold” rating in a report on Friday, December 13th. Oppenheimer reiterated an “outperform” rating and issued a $93.00 price target (up previously from $90.00) on shares of LeMaitre Vascular in a research note on Friday, November 1st. Cantor Fitzgerald assumed coverage on shares of LeMaitre Vascular in a research report on Tuesday, October 15th. They set a “neutral” rating and a $96.00 price objective for the company. Finally, Barrington Research upped their target price on LeMaitre Vascular from $92.00 to $93.00 and gave the company an “outperform” rating in a research report on Friday, November 1st. Two investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $94.57.

LeMaitre Vascular Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.